Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HCFA "inherent reasonableness" authority

This article was originally published in The Gray Sheet

Executive Summary

General Accounting Office is expected to release by mid-summer a long-awaited report on the Health Care Financing Administration's use of expanded IR authority under Sec. 4316 of the Balanced Budget Act of 1997, Rep. Bill Thomas (R-Calif.) tells a June 15 session of the American Association of Homecare conference in Washington, D.C. Thomas requested GAO to investigate whether HCFA was overstepping the bounds of its IR authority in March 1999. The agency is prohibited from using the expanded IR authority until 90 days after the release of the GAO report under the Balanced Budget Refinement Act of 1999

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel